Shanghai Runda Medical Technology Co Stock

Shanghai Runda Medical Technology Co EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Shanghai Runda Medical Technology Co (603108.SS) as of Aug 2, 2026 is 16.94. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 13.08 — a change of 29.52% (higher).

EV/EBIT

16.94

YoY

29.52%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Shanghai Runda Medical Technology Co is 2026 16.94 . EV/EBIT (Enterprise Value to EBIT) of Shanghai Runda Medical Technology Co was 2025 13.08 . It decreases by 29.52% higher compared to the previous year.

The Shanghai Runda Medical Technology Co EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2019
6.96 base
Jan 1, 2020
8.85 base
Jan 1, 2021
8.55 base
Jan 1, 2022
5.91 base
Jan 1, 2023
16.09 base
Jan 1, 2024
17.23 base
Jan 1, 2025 (e)
17.75 base
Jan 1, 2026 (e)
11.04 base
YEARPRICE-TO-EBIT
2026 est 11.04
2025 est 17.75
2024 17.23
2023 16.09
2022 5.91
2021 8.55
2020 8.85
2019 6.96
2018 5.69
2017 14.56
2016 40.95
2015 56.41
2014 -
2013 -
2012 -
Access this data via the Eulerpool API
Get Free API Key

Shanghai Runda Medical Technology Co Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Shanghai Runda Medical Technology Co's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Shanghai Runda Medical Technology Co's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Shanghai Runda Medical Technology Co's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Shanghai Runda Medical Technology Co grows earnings faster than its peers.

Shanghai Runda Medical Technology Co Stock analysis

What does Shanghai Runda Medical Technology Co do? Shanghai Runda Medical Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai Runda Medical Technology Co stock

EV/EBIT (Enterprise Value to EBIT) of Shanghai Runda Medical Technology Co is 16.94 in 2026.

Access this data via the Eulerpool API
Get Free API Key

Valuation — Shanghai Runda Medical Technology Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueEV/EBITForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Shanghai Runda Medical Technology Co